|
Homology
directed repair is essential for vertebrate cells.
Indeed, mammalian cells deficient in homologous
recombination accumulate chromosome aberrations,
which may be the result of mis-repair of one-ended
double strand breaks via non-homologous end-joining.
Consistent with this observation is the finding
that there people who inherit a deficiency in the
ability to properly perform homologous recombination
have an increased risk of cancer. Thus, too
little homologous recombination can promote cancer.
Although
homologous recombination is essential, it is also
possible that too much homologous recombination
promotes cancer. Although generally accurate,
there is a finite risk of misalignment during homologous
recombination, and this can promote tumorigenic
sequence rearrangements (e.g., deletions and insertions)
and contribute to loss of heterozygosity (caused
by replacement of the sequence on one homologous
chromosome with sequences from the other homologous
chromosome).
Most
genes known to modulate the frequency of homologous
recombination in mammals are associated with cancer.
Thus, it is clear that genomic stability,
homologous recombination, and cancer are closely
linked.
Given
the importance of this repair process, we set out
to create the first mouse model in which cells that
have undergone a homologous recombination event
can be directly detected by emission of a fluorescent
signal, and to use these mice to learn more about
how environmental and genetic factors modulate homologous
recombination in mammals in vivo.
|